No filings found
We’ll display filings we find for Shenzhen Immunofoco here
𝛼SK or SearchENTITY
Shenzhen Immunofoco (2633140D HK)
Shenzhen Immunofoco (2633140D HK)
4
Analysis
Health Care • China
Shenzhen Immunofoco Biotechnology Co., Ltd. develops innovative cell therapies. The Company produces anti-CLDN18.2 CAR-T cell therapy candidate (IMC002) for treatment of solid tumors and anti-EpCAM CAR-T cell therapy candidate (IMC001). Shenzhen Immunofoco Biotechnology conducts businesses in China.
morex